Biswas, D K <br/><br/>
The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Aug 2001 
 - 10386-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.151257998  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Base Sequence<br/>Breast Neoplasms--drug therapy<br/>Carbazoles--pharmacology<br/>Cell Division--drug effects<br/>Cyclin D1--metabolism<br/>DNA Primers--genetics<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Humans<br/>I-kappa B Kinase<br/>Indoles--pharmacology<br/>Mammary Neoplasms, Experimental--drug therapy<br/>Mice<br/>Mice, Inbred A<br/>Mutation<br/>NF-kappa B--antagonists & inhibitors<br/>Protein Kinase C--antagonists & inhibitors<br/>Protein Serine-Threonine Kinases--genetics<br/>Receptors, Estrogen--metabolism<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Transfection<br/>Tumor Cells, Cultured